Proving the Business Case for the Internet of Things

Blue Cedar protects VitalPatch wearable biosensor

Steve Rogerson
January 30, 2018



California-based Blue Cedar is using its security technology to protect the VitalPatch wearable healthcare biosensor app from VitalConnect on mobile phones and tablets. The companies will also collaborate to protect critical patient information in transit to the cloud.
 
This comes from a partnership with MediBioSense, a UK-based digital healthcare innovator and distributor of Blue Cedar’s patented code-injection technology.
 
VitalPatch is a wearable biosensor that attaches to a patient’s chest. It detects and delivers key vital signs and biometric measurements, including heart and respiratory rate, single lead ECG, and skin temperature, and then transmits the data to a mobile device before transmission and storage in the cloud.
 
“We’re excited to team with Blue Cedar to enhance mobile app protection for our flagship solution,” said MediBioSense CEO Simon Beniston. “Mobile apps and cutting-edge technology are a game-changing combination in healthcare, helping to improve lives and meet the increasingly stringent demands placed on modern healthcare services. But ultimately, these apps are only as effective as their level of security – especially with GDPR on the horizon – so we are partnering with mobile app security innovator Blue Cedar to ensure that patients’ data are secured at all times and that their privacy needs are met consistently.”
 
GDPR (General Data Protection Regulation), the pan-European data-protection law slated to take effect in May 2018, applies to European Union residents and to organisations worldwide that collect or process EU citizens’ personal data. It will require mobile enterprises to show what data are gathered, where they are stored, and how they will be safeguarded.
 
“This partnership is a natural progression for Blue Cedar as we continue our commitment to healthcare security innovation and increase our global footprint across the medical industry,” said Blue Cedar CEO John Aisien. “MediBioSense has earned its place as a true innovator that is renowned for delivering disruptive healthcare to the global market. With this new partnership, Blue Cedar will help MediBioSense secure all real-time data flowing from the VitalPatch app to any recipient database, be it a hospital database that preserves a patient’s electronic health record upon discharge, a medical trial database or a database in the cloud. For the first time, we’re enabling their solution to securely go anywhere and everywhere, while still maintaining the highest standards of data protection.”
 
The risks that insecure apps pose to hospital and patient data have been well documented for years. Nevertheless, the healthcare space continues to see a rapid proliferation of medical apps designed to help consumers track their personal health. Healthcare organisations too are increasingly aware of the need for and role of mobile devices and applications in connecting clinicians with each other and with their patients.
 
This partnership allows MediBioSense to sell VitalPatch, offering prospective customers the assurance that all data collected are secured by Blue Cedar’s technology. MediBioSense, located in Doncaster, UK, contracts with the monitoring device’s manufacturer, VitalConnect, to provide compatible software and sell the finished product.
 
VitalPatch has received Food & Drug Administration’s clearance for sale in the USAs and regulatory approval (CE Mark) for distribution in the EU.